Caribou Biosciences
CRBU
126 hedge funds and large institutions have $238M invested in Caribou Biosciences in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 48 increasing their positions, 33 reducing their positions, and 18 closing their positions.
45% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 33
2.13% more ownership
Funds ownership: 71.26% → 73.39% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less funds holding
Funds holding: 131 → 126 (-5)
12% less call options, than puts
Call options by funds: $99K | Put options by funds: $112K
13% less capital invested
Capital invested by funds: $273M → $238M (-$34.7M)
22% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$4.91M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$3.44M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.53M |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$1.25M |
| 5 |
State Street
Boston,
Massachusetts
|
+$974K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$3.04M |
| 2 |
SCM
Shelton Capital Management
Denver,
Colorado
|
-$1.01M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$832K |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$772K |
| 5 |
Two Sigma Investments
New York
|
-$766K |
CRBU Hedge Fund Activity: Q1 2023 in Review
126 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q1 2023, worth a combined $238M — down 13% from $273M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of CRBU and 14 opened new positions — a net loss of 4 holders — while 33 trimmed existing stakes and 48 added.
The largest buyer was Bank of America, adding an estimated $4.91M. The largest seller was Pictet Asset Management (Switzerland), cutting an estimated $3.04M.
- 126 institutional investors held Caribou Biosciences (CRBU) as of Q1 2023, down from 131 in Q4 2022.
- Funds reported $238M of Caribou Biosciences stock for Q1 2023, down 13% quarter-over-quarter.
- 14 funds opened new Caribou Biosciences positions in Q1 2023 and 18 closed out, a net change of -4 holders.
- The largest Caribou Biosciences buyer in Q1 2023 was Bank of America, an estimated $4.91M added.
- The largest Caribou Biosciences seller in Q1 2023 was Pictet Asset Management (Switzerland), an estimated $3.04M sold.
Based on aggregated 13F filings for Q1 2023.